India’s fifth largest pharmaceutical company Lupin Limited has informed the share market (BSE/NSE) that it will announce its result for FY11 on 12th May 2011 in a meeting of Board of Directors of the company. The company may also announce the dividend for the year ended 31st March 2011 among others. Lupin Limited, headquartered in Mumbai, India, is strongly research focused. The company has a state-of-the-art R&D center in Pune and is a leading global player in Anti-TB, Cephalosporins (anti-infectives) and Cardiovascular drugs (ACE-inhibitors and cholesterol reducing agents) and has a notable presence in the areas of diabetes, anti-inflammatory and respiratory therapy.
Share’s Data :-
BSE Code : 500257
Mkt. Cap : Rs 18,704.70 Crores
Lupin Ltd. share’s CMP is Rs 419.20 on 26th Apr 2011.
Stay tuned to BelltheBull Blog for more news on Lupin Limited !Google+